John McLean Archive — Page 1 of 1

ELVIS team leaders include, from left, Jane Freedman, MD, project leader Suman Das, PhD, Simon Mallal, MBBS, Ravi Shah, MD, John McLean, PhD. (photo by Erin O. Smith)
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.

By Paul Govern
microscope
December 28, 2015

The most popular research stories of 2015

With discoveries ranging from the origins of consciousness to the end of the universe, 2015 was a year of incredibly diverse research at Vanderbilt University.

By Vanderbilt Health News
March 10, 2015

Symposium on impact of ‘omics on medicine set for March 23

Vanderbilt and the Waters Centers of Innovation Program are sponsoring a free symposium titled “Integrated ‘Omics in Translational Medicine” on March 23. It is open to all scientists interested in the subject.

By Vanderbilt Health News
Richard Caprioli and mass spectrometer
March 3, 2014

Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells

Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.

By Bill Snyder
microbrain
July 24, 2012

Vanderbilt-led team to develop ‘microbrain’ to improve drug testing

Creating a device out of human cells that simulates brain chemistry is the goal of a $6.4 million grant which is part of major new federal initiative to develop a series of “organs on a chip” designed to improve the drug development process.

By Vanderbilt Health News